MedPath

A study of efficacy and safety of sertraline for the treatment of major depressive disorder patients, who have benn unremitted or intolerant by paroxetine or fluvoxamine

Not Applicable
Conditions
major depressive disorder
Registration Number
JPRN-UMIN000002654
Lead Sponsor
Hokkaido University Hospital, Department of Psychiatry
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
140
Inclusion Criteria

Not provided

Exclusion Criteria

1. severe physical diseases (heart, liver, kidney) 2. significant risk of suicide 3. under treatment with cognitvie-behavioral therapy of ECT 4. pregnant or breast-feeding women or women, who may be pregnant 5. organic brain disease 6. patients, whom investigaters regard as inapporopriate for subjects

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath